GPR89B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.786600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.589800E-01
Normal-vs-Stage2
6.382000E-01
Normal-vs-Stage3
4.829200E-01
Normal-vs-Stage4
8.592200E-01
Stage1-vs-Stage2
5.006600E-01
Stage1-vs-Stage3
1.720160E-01
Stage1-vs-Stage4
9.957200E-01
Stage2-vs-Stage3
1.65259994577838E-09
Stage2-vs-Stage4
3.337400E-01
Stage3-vs-Stage4
2.005400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.662400E-01
Normal-vs-AfricanAmerican
6.929600E-01
Normal-vs-Asian
5.404000E-01
Caucasian-vs-AfricanAmerican
3.527200E-01
Caucasian-vs-Asian
4.463800E-01
AfricanAmerican-vs-Asian
1.787170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.135200E-01
Normal-vs-Female
7.535600E-01
Male-vs-Female
2.011800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.234600E-01
Normal-vs-Age(41-60Yrs)
8.415400E-01
Normal-vs-Age(61-80Yrs)
6.215600E-01
Normal-vs-Age(81-100Yrs)
6.769800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.799000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.028400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.011400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.148400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.365400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.441800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.086200E-01
Normal-vs-Daily Drinker
6.239800E-01
Normal-vs-Weekly Drinker
6.541800E-01
Normal-vs-Occasional Drinker
9.558800E-01
Normal-vs-Social Drinker
4.363400E-01
Non Drinker-vs-Daily Drinker
6.981200E-01
Non Drinker-vs-Weekly Drinker
1.751010E-01
Non Drinker-vs-Occasional Drinker
6.585600E-01
Non Drinker-vs-Social Drinker
3.526000E-01
Daily Drinker-vs-Weekly Drinker
4.413000E-01
Daily Drinker-vs-Occasional Drinker
4.835200E-01
Daily Drinker-vs-Social Drinker
6.146400E-01
Weekly Drinker-vs-Occasional Drinker
2.182600E-01
Weekly Drinker-vs-Social Drinker
8.710600E-01
Occasional Drinker-vs-Social Drinker
2.926800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
N/A
Normal-vs-Grade 2
N/A
Normal-vs-Grade 3
N/A
Normal-vs-Grade 4
N/A
Grade 1-vs-Grade 2
1.760030E-01
Grade 1-vs-Grade 3
3.108000E-01
Grade 1-vs-Grade 4
N/A
Grade 2-vs-Grade 3
9.153200E-01
Grade 2-vs-Grade 4
N/A
Grade 3-vs-Grade 4
N/A
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.724600E-01
Normal-vs-NonDiabetic
7.943800E-01
Diabetic-vs-NonDiabetic
4.210500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.164400E-01
Normal-vs-NoPancreatitis
6.909400E-01
Pancreatitis-vs-NoPancreatitis
8.544000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.046600E-01
Normal-vs-N1
6.047800E-01
N0-vs-N1
3.050200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.470800E-01
Normal-vs-TP53-NonMutant
2.446800E-01
TP53-Mutant-vs-TP53-NonMutant
4.210600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
